Peer-reviewedLicence not statedBlood
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.
Related
- Harnessing Neurogenic Potential of Glial Cell Types as an Emerging Strategy for Treating Epilepsy
- Cardiolipin-Specific Targeting of Melittin via Arg22 in Lipid Membranes: A Natural Toxin-Based Strategy for Treating Mitochondrial Dysfunction in Aging and Disease.
- Placental alkaline phosphatase promotes lipid accumulation and fibrosis in ligamentum flavum hypertrophy and represents a potential target for statin repurposing
- ACSS2-mediated metabolic-epigenetic crosstalk drives Fulvestrant resistance and represents a novel therapeutic target
- Glutamine Metabolism in Cardiac Hypertrophy
BibTeX
@article{bardet2026inhibiting,
title = {{Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.}},
author = {Valérie Bardet and Willems L and Jacque N and Jacquel A and Neveux N and Maciel Tt and Lambert M and Schmitt A and Poulain L and Green As and Uzunov M and Kosmider O and Radford-Weiss I and Moura Ic and Bouscary D},
journal = {Blood},
year = {2026},
month = oct,
doi = {10.1182/blood-2013-03-493163},
url = {https://hal.science/hal-05785536v1},
}
RIS
TY - JOUR
TI - Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.
AU - Valérie Bardet
AU - Willems L
AU - Jacque N
AU - Jacquel A
AU - Neveux N
AU - Maciel Tt
AU - Lambert M
AU - Schmitt A
AU - Poulain L
AU - Green As
AU - Uzunov M
AU - Kosmider O
AU - Radford-Weiss I
AU - Moura Ic
AU - Bouscary D
PY - 2026
DA - 2026/10/08
JO - Blood
DO - 10.1182/blood-2013-03-493163
UR - https://hal.science/hal-05785536v1
SN - 0006-4971
SN - 1528-0020
ER -